Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2020 1
2021 2
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for F. khoramnia
Your search for F. Khoraminia retrieved no results
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
INTERPRETATION: Visual benefits with faricimab given at up to 16-week intervals demonstrates its potential to meaningfully extend the time between treatments with sustained efficacy, thereby reducing treatment burden in patients with nAMD. FUNDING: F Hoffmann-La Roche....
INTERPRETATION: Visual benefits with faricimab given at up to 16-week intervals demonstrates its potential to meaningfully extend the time b …
Recommendation for Presbyopia-Correcting Intraocular Lenses: A Delphi Consensus Statement by the ESASO Study Group.
Romano V, Madrid-Costa D, Alfonso JF, Alio J, Allan B, Angunawela R, Auffarth G, Carones F, Khoramnia R, Moore J, Nanavaty MA, Savini G, Pagano L, Romano MR, Virgili G, Fernández-Vega-Cueto L. Romano V, et al. Am J Ophthalmol. 2023 Sep;253:169-180. doi: 10.1016/j.ajo.2023.05.002. Epub 2023 May 24. Am J Ophthalmol. 2023. PMID: 37236521 Free article.
Comparative Surface Imaging Study of Multifocal Diffractive Intraocular Lenses.
Son HS, Lee JM, Khoramnia R, Choi CY. Son HS, et al. Klin Monbl Augenheilkd. 2022 Aug;239(8):982-990. doi: 10.1055/a-1328-2550. Epub 2021 Feb 19. Klin Monbl Augenheilkd. 2022. PMID: 33607689 English, German.
PURPOSE: To analyse and compare the surface topography and roughness of three different types of diffractive multifocal IOLs. METHODS: Using scanning electron microscope (SEM, Inspect F, 5.0 KV, maximum magnification up to 20,000) and atomic force microscope (AFM, Park Sys …
PURPOSE: To analyse and compare the surface topography and roughness of three different types of diffractive multifocal IOLs. METHODS: Using …
Long-term Clinical Outcomes After Bilateral Implantation of Two Trifocal Diffractive IOLs.
Khoramnia R, Kretz FTA, Gerl M, Breyer D, Auffarth GU. Khoramnia R, et al. J Refract Surg. 2023 Dec;39(12):798-807. doi: 10.3928/1081597X-20231006-01. Epub 2023 Dec 1. J Refract Surg. 2023. PMID: 38063832 Free article. Clinical Trial.
PURPOSE: To show clinical outcomes after bilateral implantation of either a hydrophobic FineVision POD F GF or a hydro-philic FineVision POD F intraocular lens (IOL) (Beaver-Visitec International, Inc). ...At 2 years, 81.8% and 90.5% of eyes were within 0.50 D in th …
PURPOSE: To show clinical outcomes after bilateral implantation of either a hydrophobic FineVision POD F GF or a hydro-philic FineVis …
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
Laboratory and Clinical Experience With a Diffractive Trifocal Intraocular Lens Sutured to an Artificial Iris.
Mayer CS, Son HS, Łabuz G, Baur ID, Yildirim TM, Auffarth GU, Khoramnia R. Mayer CS, et al. J Refract Surg. 2022 Jan;38(1):61-68. doi: 10.3928/1081597X-20211209-02. Epub 2022 Jan 1. J Refract Surg. 2022. PMID: 35020535
METHODS: Optical quality was analyzed by measuring the modulation transfer function (MTF) at a 3-mm aperture and at 50 and 100 lp/mm spatial frequencies. The FineVision Pod F GF IOL (PhysIOL) was assessed in two powers: two +20.00 diopters (D) (20A and 20B IOLs) and two +3 …
METHODS: Optical quality was analyzed by measuring the modulation transfer function (MTF) at a 3-mm aperture and at 50 and 100 lp/mm spatial …
Evaluation of Ocular Diameter Parameters Using Swept-Source Optical Coherence Tomography.
Dong J, Yao J, Chang S, Kanclerz P, Khoramnia R, Wang X. Dong J, et al. Medicina (Kaunas). 2023 May 8;59(5):899. doi: 10.3390/medicina59050899. Medicina (Kaunas). 2023. PMID: 37241130 Free PMC article.
Results: ATA and STS were the longest on the vertical and shortest on the horizontal axis, while WTW was similar on both axes. These three parameters differed only in the vertical axis (F = 4.910, p = 0.008). ATA and STS were by 0.23 0.08 mm (p = 0.005) and 0.21 0.08 mm wi …
Results: ATA and STS were the longest on the vertical and shortest on the horizontal axis, while WTW was similar on both axes. These three p …
12 results